NO20012348L - Fremgangsmåte for fremstilling av orale kalsiumblandinger - Google Patents

Fremgangsmåte for fremstilling av orale kalsiumblandinger

Info

Publication number
NO20012348L
NO20012348L NO20012348A NO20012348A NO20012348L NO 20012348 L NO20012348 L NO 20012348L NO 20012348 A NO20012348 A NO 20012348A NO 20012348 A NO20012348 A NO 20012348A NO 20012348 L NO20012348 L NO 20012348L
Authority
NO
Norway
Prior art keywords
granulate
preparation
produce
mixing
calcium compound
Prior art date
Application number
NO20012348A
Other languages
English (en)
Other versions
NO331462B1 (no
NO20012348D0 (no
Inventor
Jan Yngvar Piene
Dina Dogger Schmidt
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of NO20012348D0 publication Critical patent/NO20012348D0/no
Publication of NO20012348L publication Critical patent/NO20012348L/no
Publication of NO331462B1 publication Critical patent/NO331462B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
NO20012348A 1998-11-13 2001-05-11 Fremgangsmåte for fremstilling av en oralt administrerbar kalsiumblanding i tablettform NO331462B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9825033.5A GB9825033D0 (en) 1998-11-13 1998-11-13 Process
PCT/GB1999/003666 WO2000028973A1 (en) 1998-11-13 1999-11-05 Process for preparing oral calcium compositions

Publications (3)

Publication Number Publication Date
NO20012348D0 NO20012348D0 (no) 2001-05-11
NO20012348L true NO20012348L (no) 2001-07-03
NO331462B1 NO331462B1 (no) 2012-01-09

Family

ID=10842483

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012348A NO331462B1 (no) 1998-11-13 2001-05-11 Fremgangsmåte for fremstilling av en oralt administrerbar kalsiumblanding i tablettform

Country Status (22)

Country Link
US (3) US20050232989A1 (no)
EP (2) EP1743629A1 (no)
JP (1) JP4213867B2 (no)
CN (1) CN1183902C (no)
AT (1) ATE342714T1 (no)
AU (1) AU6481999A (no)
CA (1) CA2349565C (no)
CY (1) CY1106299T1 (no)
DE (1) DE69933689T2 (no)
DK (1) DK1128815T3 (no)
EA (1) EA004951B1 (no)
EE (1) EE04740B1 (no)
ES (1) ES2273510T3 (no)
GB (1) GB9825033D0 (no)
HK (1) HK1040615B (no)
NO (1) NO331462B1 (no)
PL (1) PL197146B1 (no)
PT (1) PT1128815E (no)
SI (1) SI1128815T1 (no)
TR (1) TR200101347T2 (no)
UA (1) UA73727C2 (no)
WO (1) WO2000028973A1 (no)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
WO2003013270A2 (en) * 2001-08-09 2003-02-20 Rhodia Inc. Calcium dietary supplement
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
JP4601934B2 (ja) * 2003-10-06 2010-12-22 ナガセ医薬品株式会社 ユビデカレノン錠
US8062659B2 (en) * 2004-02-20 2011-11-22 Novartis Ag Dietary fiber composition
JP4566598B2 (ja) * 2004-03-29 2010-10-20 日本製紙株式会社 キャスト塗工紙及びその製造方法
CN1964701A (zh) * 2004-05-04 2007-05-16 罗迪亚公司 可直接压制的磷酸三钙
TWI356712B (en) 2004-05-24 2012-01-21 Nycomed Pharma As Agglomeration of a calcium-containing compound by
EA011931B1 (ru) * 2004-06-01 2009-06-30 Никомед Фарма Ас Жевательная таблетка, таблетка для рассасывания и таблетка для глотания, содержащая кальцийсодержащее соединение в качестве активного вещества
JP2006111582A (ja) * 2004-10-15 2006-04-27 Suntory Ltd カルシウム含有顆粒の製造方法
NZ556465A (en) * 2005-02-03 2010-10-29 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
EP1845949B1 (en) * 2005-02-03 2008-05-21 Nycomed Pharma AS Melt granulation of a composition containing a calcium-containing compound
ES2324957T5 (es) * 2005-03-04 2012-08-21 Nycomed Pharma As Proceso para la producción de composiciones de calcio en un lecho fluido continuo
US20070003611A1 (en) * 2005-06-29 2007-01-04 Sung-Tsuen Liu Novel method of granulating calcium carbonate and products provided therefrom
GB0522045D0 (en) * 2005-10-28 2005-12-07 Novartis Ag Pharmaceutical compositions
JP5420907B2 (ja) * 2005-12-07 2014-02-19 タケダ ニコメド エイエス 予備圧縮されたカルシウム含有化合物
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
IN2014DN03102A (no) 2006-11-07 2015-07-10 Procter & Gamble
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
CA2835910C (en) * 2007-04-25 2016-06-28 Warner Chilcott Company, Llc Improved vitamin d content uniformity in pharmaceutical dosage forms
US8741918B2 (en) * 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
US9386783B2 (en) * 2007-07-31 2016-07-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Confectionery products and process for obtaining them
JP5490691B2 (ja) * 2008-06-12 2014-05-14 株式会社三和化学研究所 炭酸カルシウム含有速崩壊性製剤
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
CA2742449C (en) 2008-11-17 2018-04-24 Nycomed Pharma As Improved dissolution stability of calcium carbonate tablets
BE1018560A3 (fr) * 2008-12-24 2011-03-01 Galactic Sa Lactate de calcium solide de forme substantiellement spherique.
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
JP2011046621A (ja) * 2009-08-25 2011-03-10 Kao Corp カルシウム化合物とセルロースの混合粉砕物の製造方法
CN102067997B (zh) * 2009-11-25 2013-08-21 上海诺成药业股份有限公司 高密度碳酸钙颗粒
CN102106870B (zh) * 2009-11-25 2015-01-21 上海诺成药业股份有限公司 高密度碳酸钙颗粒的制造方法
WO2011113965A1 (es) * 2010-03-18 2011-09-22 Farmalider, S.A. Composición farmacéutica en forma sólida que contiene isoflavonas, una sal de calcio y vitamina d3
CN102232967A (zh) * 2010-04-21 2011-11-09 武汉同济现代医药有限公司 一种新型口服补钙泡腾剂及其制备方法
GR1007316B (el) * 2010-05-31 2011-06-14 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Φαρμακευτικη συνθεση δισκιων ανθρακικου ασβεστιου
US20120121703A1 (en) * 2010-07-20 2012-05-17 Japan Tobacco Inc. Tablet containing ferric citrate
DE102010043318A1 (de) * 2010-11-03 2012-05-03 Klaus F. Kopp Calciumcarbonat enthaltende Zusammensetzung
AR089857A1 (es) * 2012-02-02 2014-09-24 Glaxosmithkline Llc Comprimido antiacido para refrescar el aliento
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
AU2013274378B2 (en) 2012-06-12 2016-06-02 The Procter & Gamble Company Effervescent dosage form
WO2014021718A1 (en) 2012-08-01 2014-02-06 Purac Biochem B.V. Lactate powder and method for the preparation thereof
EP2769630B1 (en) 2013-02-26 2016-04-27 Purac Biochem N.V. Improved nisin production process
EP2754356A1 (en) 2013-01-15 2014-07-16 Purac Biochem N.V. Improved nisin production process
US10314771B2 (en) * 2013-02-28 2019-06-11 University Of Tennessee Research Foundation Methods and compositions for preventing and treating tooth erosion
CN103169092A (zh) * 2013-03-21 2013-06-26 翁国富 一种l-天门冬氨酸螯和钙水
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
WO2015023773A2 (en) 2013-08-14 2015-02-19 University Of Tennessee Research Foundation Tooth remineralization compositions and methods
CN106265725B (zh) * 2015-05-14 2021-02-09 北京科信必成医药科技发展有限公司 一种碳酸钙掩味颗粒剂及其制备方法
CN105106233A (zh) * 2015-08-28 2015-12-02 江苏福邦药业有限公司 一种高溶出度小儿碳酸钙d3颗粒及其制备方法
WO2017207569A1 (en) * 2016-06-02 2017-12-07 Nestec S.A. Co-crystalline sucrose
CN108478595B (zh) * 2018-05-01 2021-07-02 海南施宝生物科技有限公司 一种含有碳酸钙、维生素d3、维生素k2的药物组合物
ES2945809T3 (es) 2019-10-02 2023-07-07 Intas Pharmaceuticals Ltd Composiciones farmacéuticas sólidas efervescentes prácticamente sin sodio
CN112042946A (zh) * 2020-07-20 2020-12-08 深圳市味奇生物科技有限公司 富含益生元的高钙组合物及其制备方法
US20220110900A1 (en) * 2020-10-09 2022-04-14 Nutrient Density Technology, LLC Solid nutrient compositions and associated methods
CN113679675B (zh) * 2021-09-10 2023-04-07 新疆特丰药业股份有限公司 一种钙颗粒剂及其制备方法和用途
CN113975240B (zh) * 2021-11-22 2023-06-27 国圣制药(上海)有限公司 一种钙维生素d片生产方法
CN115581677A (zh) * 2022-10-12 2023-01-10 河北菲尼斯生物技术有限公司 一种包含碳酸钙和维生素d3的咀嚼片及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
CA1279574C (en) * 1985-04-17 1991-01-29 Jeffrey L. Finnan Process for lubricating water-soluble vitamin powders
US4814177A (en) * 1986-03-18 1989-03-21 Board Of Regents, University Of Texas System Ultradense and more soluble and bioavailable preparations of calcium citrate
DE4006734C1 (no) * 1990-03-03 1991-07-25 Benckiser-Knapsack Gmbh, 6802 Ladenburg, De
NZ239802A (en) * 1990-09-21 1993-09-27 Merrell Dow Pharma A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production
ES2066092T3 (es) * 1990-11-29 1995-03-01 Wei Ming Pharmaceutical Mfg Co Coadyuvante para la formacion directa de comprimidos.
US5629013A (en) * 1991-04-04 1997-05-13 The Procter & Gamble Company Chewable calcium carbonate antacid tablet compositions
JP2702325B2 (ja) * 1991-08-01 1998-01-21 帝人株式会社 顆粒状カルシウム組成物及びそれからなる錠剤
JP2995226B2 (ja) 1992-03-03 1999-12-27 日本ワイスレダリー株式会社 カルシウム含有チユアブル錠
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
US6066342A (en) * 1995-12-22 2000-05-23 Tamer International, Ltd. Antacid composition
DE19617487A1 (de) * 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
JPH10114653A (ja) * 1996-10-11 1998-05-06 Taishi Shokuhin Kogyo Kk 骨形成促進および骨塩量減少防止用組成物
US6114289A (en) * 1997-03-11 2000-09-05 The Procter & Gamble Company Encapsulated crystalline calcium carbonate builder for use in detergent compositions
US6096343A (en) * 1997-10-27 2000-08-01 Gerhard Gergely Instant calcium/soybean granules, their use and process for their preparation
EP1067943A4 (en) * 1998-03-11 2008-09-24 Smithkline Beecham Corp PROCESS FOR PRODUCING AQUEOUS SUSPENSION OF CALCIUM CARBONATE
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6296868B1 (en) * 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
US20040071772A1 (en) * 2001-03-06 2004-04-15 Shoichi Narita Preparations quickly disintegrating in oral cavity

Also Published As

Publication number Publication date
EP1743629A1 (en) 2007-01-17
WO2000028973A1 (en) 2000-05-25
GB9825033D0 (en) 1999-01-13
PT1128815E (pt) 2007-01-31
HK1040615A1 (en) 2002-06-21
DK1128815T3 (da) 2007-02-05
ES2273510T3 (es) 2007-05-01
DE69933689T2 (de) 2007-08-23
US7638143B2 (en) 2009-12-29
NO331462B1 (no) 2012-01-09
CN1326338A (zh) 2001-12-12
DE69933689D1 (de) 2006-11-30
NO20012348D0 (no) 2001-05-11
US20070224268A1 (en) 2007-09-27
EE200100260A (et) 2002-12-16
EP1128815B1 (en) 2006-10-18
TR200101347T2 (tr) 2001-08-21
EE04740B1 (et) 2006-12-15
US20100119621A1 (en) 2010-05-13
AU6481999A (en) 2000-06-05
US20050232989A1 (en) 2005-10-20
CA2349565C (en) 2007-01-16
US8007752B2 (en) 2011-08-30
SI1128815T1 (sl) 2007-04-30
JP2002529496A (ja) 2002-09-10
CA2349565A1 (en) 2000-05-25
CN1183902C (zh) 2005-01-12
PL348040A1 (en) 2002-05-06
EP1128815A1 (en) 2001-09-05
HK1040615B (zh) 2007-05-25
UA73727C2 (uk) 2005-09-15
EA200100415A1 (ru) 2001-12-24
EA004951B1 (ru) 2004-10-28
ATE342714T1 (de) 2006-11-15
CY1106299T1 (el) 2011-10-12
JP4213867B2 (ja) 2009-01-21
PL197146B1 (pl) 2008-03-31

Similar Documents

Publication Publication Date Title
NO20012348L (no) Fremgangsmåte for fremstilling av orale kalsiumblandinger
CA2051531A1 (en) Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition
BR0206164A (pt) Partìculas cristalinas de oxalato de escitalopram, método para a produção de partìculas cristalinas de oxalato de escitalopram, e, forma de dosagem unitária sólida
WO2004022601A3 (en) Compositions for industrial applications
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
ZA959473B (en) Pharmaceutical composition for oral administation of flavonoids
JPS57140711A (en) Poultice for anti-inflammatory and analgesic use and its preparation
CA2166001A1 (en) Stable solid formulation of enalapril salt and process for preparation thereof
ES2196743T3 (es) Sorbitol en polvo y su procedimiento de preparacion.
JPS5753403A (en) Composition containing spray dry particle of n-acetyl-p-aminophenol and manufacture
ATE297192T1 (de) Tabletten und verfahren zur tablettenherstellung
PL144064B1 (en) Method of obtaining basic pyroxene salt on an pharmacologically compatible carrier
KR940006583A (ko) 약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질
AU2001289708A1 (en) Method for producing a crystalline tableting additive, additive thus obtained and use thereof
RU2000112305A (ru) Способ приготовления вспучивающей добавки
DE60009889D1 (de) Gipsverzögererzusammensetzung
SU1390219A1 (ru) Способ приготовлени фарфорового шликера
RU97121841A (ru) Фармацевтическая композиция и способ ее получения
RU98111244A (ru) Комплексная добавка для бетонной смеси
CA2345737A1 (en) Process for delivering chelant agglomerate into detergent composition for improving its storage stability, flowability and scoopability
RU97104855A (ru) Способ получения синтетического фожазита
RU97114057A (ru) Способ подготовки стекольной шихты
RU97113732A (ru) Реагент для глинистых буровых растворов
RU92005197A (ru) Способ получения минерального вяжущего

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA AS, NO

MK1K Patent expired